nodes	percent_of_prediction	percent_of_DWPC	metapath
Arformoterol—ADRB2—Metipranolol—glaucoma	0.0797	0.101	CbGbCtD
Arformoterol—ADRB2—Levobunolol—glaucoma	0.0797	0.101	CbGbCtD
Arformoterol—ADRB1—Metipranolol—glaucoma	0.0785	0.099	CbGbCtD
Arformoterol—ADRB1—Levobunolol—glaucoma	0.0785	0.099	CbGbCtD
Arformoterol—ADRB2—Carteolol—glaucoma	0.0678	0.0855	CbGbCtD
Arformoterol—ADRB1—Carteolol—glaucoma	0.0668	0.0842	CbGbCtD
Arformoterol—ADRB2—Dipivefrin—glaucoma	0.0483	0.0609	CbGbCtD
Arformoterol—ADRB2—Betaxolol—glaucoma	0.0458	0.0577	CbGbCtD
Arformoterol—ADRB1—Betaxolol—glaucoma	0.0451	0.0569	CbGbCtD
Arformoterol—CYP2A6—Pilocarpine—glaucoma	0.041	0.0517	CbGbCtD
Arformoterol—ADRB2—Timolol—glaucoma	0.0295	0.0372	CbGbCtD
Arformoterol—ADRB1—Timolol—glaucoma	0.0291	0.0366	CbGbCtD
Arformoterol—CYP2D6—Carteolol—glaucoma	0.017	0.0214	CbGbCtD
Arformoterol—CYP2D6—Betaxolol—glaucoma	0.0115	0.0145	CbGbCtD
Arformoterol—CYP2C19—Methazolamide—glaucoma	0.0115	0.0144	CbGbCtD
Arformoterol—CYP2C9—Diclofenamide—glaucoma	0.0111	0.0139	CbGbCtD
Arformoterol—CYP2C9—Dorzolamide—glaucoma	0.0107	0.0135	CbGbCtD
Arformoterol—CYP2C19—Timolol—glaucoma	0.00974	0.0123	CbGbCtD
Arformoterol—CYP2C9—Methazolamide—glaucoma	0.00952	0.012	CbGbCtD
Arformoterol—CYP2D6—Methazolamide—glaucoma	0.00871	0.011	CbGbCtD
Arformoterol—CYP2D6—Timolol—glaucoma	0.0074	0.00933	CbGbCtD
Arformoterol—CYP2D6—Clonidine—glaucoma	0.00629	0.00793	CbGbCtD
Arformoterol—Dobutamine—CA5A—glaucoma	0.00265	0.71	CrCbGaD
Arformoterol—ADRB2—Treprostinil—Latanoprost—glaucoma	0.00224	1	CbGdCrCtD
Arformoterol—Dobutamine—CA2—glaucoma	0.00108	0.29	CrCbGaD
Arformoterol—Asthenia—Apraclonidine—glaucoma	0.000124	0.000621	CcSEcCtD
Arformoterol—Somnolence—Brinzolamide—glaucoma	0.000124	0.00062	CcSEcCtD
Arformoterol—Urticaria—Acetazolamide—glaucoma	0.000123	0.000615	CcSEcCtD
Arformoterol—Tremor—Clonidine—glaucoma	0.000123	0.000615	CcSEcCtD
Arformoterol—Dyspepsia—Brinzolamide—glaucoma	0.000122	0.000614	CcSEcCtD
Arformoterol—Pruritus—Apraclonidine—glaucoma	0.000122	0.000612	CcSEcCtD
Arformoterol—Body temperature increased—Acetazolamide—glaucoma	0.000122	0.000612	CcSEcCtD
Arformoterol—Fatigue—Dorzolamide—glaucoma	0.000122	0.000612	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000122	0.000611	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Travoprost—glaucoma	0.000122	0.00061	CcSEcCtD
Arformoterol—Fatigue—Travoprost—glaucoma	0.000122	0.000609	CcSEcCtD
Arformoterol—Cardiac disorder—Betaxolol—glaucoma	0.000121	0.000609	CcSEcCtD
Arformoterol—Ill-defined disorder—Clonidine—glaucoma	0.000121	0.000609	CcSEcCtD
Arformoterol—Pain—Dorzolamide—glaucoma	0.000121	0.000607	CcSEcCtD
Arformoterol—Insomnia—Pilocarpine—glaucoma	0.000121	0.000606	CcSEcCtD
Arformoterol—Constipation—Travoprost—glaucoma	0.000121	0.000604	CcSEcCtD
Arformoterol—Pain—Travoprost—glaucoma	0.000121	0.000604	CcSEcCtD
Arformoterol—Hyperglycaemia—Timolol—glaucoma	0.000121	0.000604	CcSEcCtD
Arformoterol—Agitation—Clonidine—glaucoma	0.00012	0.000603	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Brinzolamide—glaucoma	0.00012	0.000602	CcSEcCtD
Arformoterol—Asthenia—Bimatoprost—glaucoma	0.00012	0.000602	CcSEcCtD
Arformoterol—Fatigue—Brinzolamide—glaucoma	0.00012	0.000601	CcSEcCtD
Arformoterol—Angioedema—Clonidine—glaucoma	0.00012	0.000599	CcSEcCtD
Arformoterol—Dyspnoea—Pilocarpine—glaucoma	0.000119	0.000598	CcSEcCtD
Arformoterol—Pain—Brinzolamide—glaucoma	0.000119	0.000596	CcSEcCtD
Arformoterol—Somnolence—Pilocarpine—glaucoma	0.000119	0.000596	CcSEcCtD
Arformoterol—Pruritus—Bimatoprost—glaucoma	0.000118	0.000593	CcSEcCtD
Arformoterol—Immune system disorder—Betaxolol—glaucoma	0.000118	0.000592	CcSEcCtD
Arformoterol—Diarrhoea—Apraclonidine—glaucoma	0.000118	0.000592	CcSEcCtD
Arformoterol—Malaise—Clonidine—glaucoma	0.000118	0.000591	CcSEcCtD
Arformoterol—Mediastinal disorder—Betaxolol—glaucoma	0.000118	0.000591	CcSEcCtD
Arformoterol—Dyspepsia—Pilocarpine—glaucoma	0.000118	0.00059	CcSEcCtD
Arformoterol—Arrhythmia—Betaxolol—glaucoma	0.000117	0.000586	CcSEcCtD
Arformoterol—Feeling abnormal—Dorzolamide—glaucoma	0.000117	0.000585	CcSEcCtD
Arformoterol—Feeling abnormal—Travoprost—glaucoma	0.000116	0.000582	CcSEcCtD
Arformoterol—Conjunctivitis—Timolol—glaucoma	0.000116	0.00058	CcSEcCtD
Arformoterol—Gastrointestinal pain—Dorzolamide—glaucoma	0.000116	0.00058	CcSEcCtD
Arformoterol—Palpitations—Clonidine—glaucoma	0.000116	0.00058	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000115	0.000579	CcSEcCtD
Arformoterol—Gastrointestinal pain—Travoprost—glaucoma	0.000115	0.000578	CcSEcCtD
Arformoterol—Feeling abnormal—Brinzolamide—glaucoma	0.000115	0.000575	CcSEcCtD
Arformoterol—Mental disorder—Betaxolol—glaucoma	0.000115	0.000575	CcSEcCtD
Arformoterol—Constipation—Pilocarpine—glaucoma	0.000114	0.000573	CcSEcCtD
Arformoterol—Pain—Pilocarpine—glaucoma	0.000114	0.000573	CcSEcCtD
Arformoterol—Cough—Clonidine—glaucoma	0.000114	0.000572	CcSEcCtD
Arformoterol—Dizziness—Apraclonidine—glaucoma	0.000114	0.000572	CcSEcCtD
Arformoterol—Malnutrition—Betaxolol—glaucoma	0.000114	0.000571	CcSEcCtD
Arformoterol—Urticaria—Dorzolamide—glaucoma	0.000112	0.000564	CcSEcCtD
Arformoterol—Abdominal pain—Dorzolamide—glaucoma	0.000112	0.000561	CcSEcCtD
Arformoterol—Body temperature increased—Dorzolamide—glaucoma	0.000112	0.000561	CcSEcCtD
Arformoterol—Tension—Betaxolol—glaucoma	0.000112	0.00056	CcSEcCtD
Arformoterol—Sinusitis—Timolol—glaucoma	0.000112	0.00056	CcSEcCtD
Arformoterol—Dysgeusia—Betaxolol—glaucoma	0.000112	0.000559	CcSEcCtD
Arformoterol—Arthralgia—Clonidine—glaucoma	0.000111	0.000558	CcSEcCtD
Arformoterol—Chest pain—Clonidine—glaucoma	0.000111	0.000558	CcSEcCtD
Arformoterol—Abdominal pain—Travoprost—glaucoma	0.000111	0.000558	CcSEcCtD
Arformoterol—Anxiety—Clonidine—glaucoma	0.000111	0.000556	CcSEcCtD
Arformoterol—Asthenia—Acetazolamide—glaucoma	0.000111	0.000555	CcSEcCtD
Arformoterol—Dizziness—Bimatoprost—glaucoma	0.000111	0.000555	CcSEcCtD
Arformoterol—Nervousness—Betaxolol—glaucoma	0.000111	0.000555	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000111	0.000555	CcSEcCtD
Arformoterol—Urticaria—Brinzolamide—glaucoma	0.000111	0.000554	CcSEcCtD
Arformoterol—Feeling abnormal—Pilocarpine—glaucoma	0.00011	0.000552	CcSEcCtD
Arformoterol—Discomfort—Clonidine—glaucoma	0.00011	0.000552	CcSEcCtD
Arformoterol—Vomiting—Apraclonidine—glaucoma	0.00011	0.00055	CcSEcCtD
Arformoterol—Muscle spasms—Betaxolol—glaucoma	0.00011	0.000549	CcSEcCtD
Arformoterol—Gastrointestinal pain—Pilocarpine—glaucoma	0.000109	0.000548	CcSEcCtD
Arformoterol—Hypersensitivity—Brimonidine—glaucoma	0.000109	0.000547	CcSEcCtD
Arformoterol—Dry mouth—Clonidine—glaucoma	0.000109	0.000546	CcSEcCtD
Arformoterol—Dermatitis—Apraclonidine—glaucoma	0.000109	0.000545	CcSEcCtD
Arformoterol—Headache—Apraclonidine—glaucoma	0.000108	0.000542	CcSEcCtD
Arformoterol—Rhinitis—Timolol—glaucoma	0.000107	0.000537	CcSEcCtD
Arformoterol—Oedema—Clonidine—glaucoma	0.000107	0.000535	CcSEcCtD
Arformoterol—Tremor—Betaxolol—glaucoma	0.000107	0.000535	CcSEcCtD
Arformoterol—Asthenia—Brimonidine—glaucoma	0.000106	0.000533	CcSEcCtD
Arformoterol—Infection—Clonidine—glaucoma	0.000106	0.000532	CcSEcCtD
Arformoterol—Body temperature increased—Pilocarpine—glaucoma	0.000106	0.00053	CcSEcCtD
Arformoterol—Abdominal pain—Pilocarpine—glaucoma	0.000106	0.00053	CcSEcCtD
Arformoterol—Ill-defined disorder—Betaxolol—glaucoma	0.000106	0.00053	CcSEcCtD
Arformoterol—Diarrhoea—Acetazolamide—glaucoma	0.000106	0.00053	CcSEcCtD
Arformoterol—Rash—Bimatoprost—glaucoma	0.000106	0.000529	CcSEcCtD
Arformoterol—Dermatitis—Bimatoprost—glaucoma	0.000105	0.000528	CcSEcCtD
Arformoterol—Oedema peripheral—Timolol—glaucoma	0.000105	0.000528	CcSEcCtD
Arformoterol—Connective tissue disorder—Timolol—glaucoma	0.000105	0.000527	CcSEcCtD
Arformoterol—Pruritus—Brimonidine—glaucoma	0.000105	0.000526	CcSEcCtD
Arformoterol—Headache—Bimatoprost—glaucoma	0.000105	0.000526	CcSEcCtD
Arformoterol—Nervous system disorder—Clonidine—glaucoma	0.000105	0.000525	CcSEcCtD
Arformoterol—Hypersensitivity—Dorzolamide—glaucoma	0.000104	0.000523	CcSEcCtD
Arformoterol—Tachycardia—Clonidine—glaucoma	0.000104	0.000522	CcSEcCtD
Arformoterol—Hypersensitivity—Travoprost—glaucoma	0.000104	0.00052	CcSEcCtD
Arformoterol—Skin disorder—Clonidine—glaucoma	0.000104	0.00052	CcSEcCtD
Arformoterol—Visual impairment—Timolol—glaucoma	0.000103	0.000516	CcSEcCtD
Arformoterol—Malaise—Betaxolol—glaucoma	0.000103	0.000515	CcSEcCtD
Arformoterol—Nausea—Apraclonidine—glaucoma	0.000103	0.000514	CcSEcCtD
Arformoterol—Hypersensitivity—Brinzolamide—glaucoma	0.000103	0.000514	CcSEcCtD
Arformoterol—Dizziness—Acetazolamide—glaucoma	0.000102	0.000512	CcSEcCtD
Arformoterol—Asthenia—Dorzolamide—glaucoma	0.000102	0.000509	CcSEcCtD
Arformoterol—Asthenia—Travoprost—glaucoma	0.000101	0.000507	CcSEcCtD
Arformoterol—Palpitations—Betaxolol—glaucoma	0.000101	0.000505	CcSEcCtD
Arformoterol—Pruritus—Dorzolamide—glaucoma	0.0001	0.000502	CcSEcCtD
Arformoterol—Asthenia—Brinzolamide—glaucoma	9.98e-05	0.0005	CcSEcCtD
Arformoterol—Hypotension—Clonidine—glaucoma	9.98e-05	0.0005	CcSEcCtD
Arformoterol—Pruritus—Travoprost—glaucoma	9.97e-05	0.0005	CcSEcCtD
Arformoterol—Cough—Betaxolol—glaucoma	9.94e-05	0.000498	CcSEcCtD
Arformoterol—Nausea—Bimatoprost—glaucoma	9.94e-05	0.000498	CcSEcCtD
Arformoterol—Cardiac disorder—Timolol—glaucoma	9.92e-05	0.000497	CcSEcCtD
Arformoterol—Hypersensitivity—Pilocarpine—glaucoma	9.85e-05	0.000494	CcSEcCtD
Arformoterol—Pruritus—Brinzolamide—glaucoma	9.85e-05	0.000493	CcSEcCtD
Arformoterol—Vomiting—Acetazolamide—glaucoma	9.82e-05	0.000492	CcSEcCtD
Arformoterol—Dizziness—Brimonidine—glaucoma	9.8e-05	0.000491	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Clonidine—glaucoma	9.73e-05	0.000488	CcSEcCtD
Arformoterol—Arthralgia—Betaxolol—glaucoma	9.7e-05	0.000486	CcSEcCtD
Arformoterol—Myalgia—Betaxolol—glaucoma	9.7e-05	0.000486	CcSEcCtD
Arformoterol—Chest pain—Betaxolol—glaucoma	9.7e-05	0.000486	CcSEcCtD
Arformoterol—Diarrhoea—Dorzolamide—glaucoma	9.68e-05	0.000485	CcSEcCtD
Arformoterol—Headache—Acetazolamide—glaucoma	9.67e-05	0.000485	CcSEcCtD
Arformoterol—Anxiety—Betaxolol—glaucoma	9.67e-05	0.000484	CcSEcCtD
Arformoterol—Insomnia—Clonidine—glaucoma	9.66e-05	0.000484	CcSEcCtD
Arformoterol—Immune system disorder—Timolol—glaucoma	9.66e-05	0.000484	CcSEcCtD
Arformoterol—Diarrhoea—Travoprost—glaucoma	9.64e-05	0.000483	CcSEcCtD
Arformoterol—Mediastinal disorder—Timolol—glaucoma	9.64e-05	0.000483	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	9.63e-05	0.000483	CcSEcCtD
Arformoterol—Asthenia—Pilocarpine—glaucoma	9.6e-05	0.000481	CcSEcCtD
Arformoterol—Discomfort—Betaxolol—glaucoma	9.58e-05	0.00048	CcSEcCtD
Arformoterol—Arrhythmia—Timolol—glaucoma	9.55e-05	0.000479	CcSEcCtD
Arformoterol—Dyspnoea—Clonidine—glaucoma	9.52e-05	0.000477	CcSEcCtD
Arformoterol—Diarrhoea—Brinzolamide—glaucoma	9.52e-05	0.000477	CcSEcCtD
Arformoterol—Somnolence—Clonidine—glaucoma	9.5e-05	0.000476	CcSEcCtD
Arformoterol—Dry mouth—Betaxolol—glaucoma	9.49e-05	0.000475	CcSEcCtD
Arformoterol—Pruritus—Pilocarpine—glaucoma	9.46e-05	0.000474	CcSEcCtD
Arformoterol—Mental disorder—Timolol—glaucoma	9.37e-05	0.000469	CcSEcCtD
Arformoterol—Dizziness—Dorzolamide—glaucoma	9.36e-05	0.000469	CcSEcCtD
Arformoterol—Rash—Brimonidine—glaucoma	9.35e-05	0.000468	CcSEcCtD
Arformoterol—Dermatitis—Brimonidine—glaucoma	9.34e-05	0.000468	CcSEcCtD
Arformoterol—Dizziness—Travoprost—glaucoma	9.32e-05	0.000467	CcSEcCtD
Arformoterol—Malnutrition—Timolol—glaucoma	9.31e-05	0.000466	CcSEcCtD
Arformoterol—Oedema—Betaxolol—glaucoma	9.3e-05	0.000466	CcSEcCtD
Arformoterol—Headache—Brimonidine—glaucoma	9.29e-05	0.000465	CcSEcCtD
Arformoterol—Infection—Betaxolol—glaucoma	9.24e-05	0.000463	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Clonidine—glaucoma	9.22e-05	0.000462	CcSEcCtD
Arformoterol—Fatigue—Clonidine—glaucoma	9.21e-05	0.000462	CcSEcCtD
Arformoterol—Dizziness—Brinzolamide—glaucoma	9.2e-05	0.000461	CcSEcCtD
Arformoterol—Nausea—Acetazolamide—glaucoma	9.17e-05	0.00046	CcSEcCtD
Arformoterol—Diarrhoea—Pilocarpine—glaucoma	9.15e-05	0.000459	CcSEcCtD
Arformoterol—Tension—Timolol—glaucoma	9.13e-05	0.000458	CcSEcCtD
Arformoterol—Pain—Clonidine—glaucoma	9.13e-05	0.000458	CcSEcCtD
Arformoterol—Constipation—Clonidine—glaucoma	9.13e-05	0.000458	CcSEcCtD
Arformoterol—Nervous system disorder—Betaxolol—glaucoma	9.12e-05	0.000457	CcSEcCtD
Arformoterol—Dysgeusia—Timolol—glaucoma	9.12e-05	0.000457	CcSEcCtD
Arformoterol—Tachycardia—Betaxolol—glaucoma	9.08e-05	0.000455	CcSEcCtD
Arformoterol—Nervousness—Timolol—glaucoma	9.04e-05	0.000453	CcSEcCtD
Arformoterol—Skin disorder—Betaxolol—glaucoma	9.03e-05	0.000453	CcSEcCtD
Arformoterol—Vomiting—Dorzolamide—glaucoma	9e-05	0.000451	CcSEcCtD
Arformoterol—Rash—Dorzolamide—glaucoma	8.92e-05	0.000447	CcSEcCtD
Arformoterol—Dermatitis—Dorzolamide—glaucoma	8.92e-05	0.000447	CcSEcCtD
Arformoterol—Rash—Travoprost—glaucoma	8.89e-05	0.000445	CcSEcCtD
Arformoterol—Dermatitis—Travoprost—glaucoma	8.88e-05	0.000445	CcSEcCtD
Arformoterol—Headache—Dorzolamide—glaucoma	8.87e-05	0.000444	CcSEcCtD
Arformoterol—Vomiting—Brinzolamide—glaucoma	8.85e-05	0.000443	CcSEcCtD
Arformoterol—Dizziness—Pilocarpine—glaucoma	8.84e-05	0.000443	CcSEcCtD
Arformoterol—Headache—Travoprost—glaucoma	8.83e-05	0.000442	CcSEcCtD
Arformoterol—Nausea—Brimonidine—glaucoma	8.8e-05	0.000441	CcSEcCtD
Arformoterol—Feeling abnormal—Clonidine—glaucoma	8.8e-05	0.000441	CcSEcCtD
Arformoterol—Rash—Brinzolamide—glaucoma	8.77e-05	0.00044	CcSEcCtD
Arformoterol—Dermatitis—Brinzolamide—glaucoma	8.77e-05	0.000439	CcSEcCtD
Arformoterol—Gastrointestinal pain—Clonidine—glaucoma	8.73e-05	0.000438	CcSEcCtD
Arformoterol—Headache—Brinzolamide—glaucoma	8.72e-05	0.000437	CcSEcCtD
Arformoterol—Hypotension—Betaxolol—glaucoma	8.69e-05	0.000435	CcSEcCtD
Arformoterol—Angioedema—Timolol—glaucoma	8.51e-05	0.000426	CcSEcCtD
Arformoterol—Vomiting—Pilocarpine—glaucoma	8.5e-05	0.000426	CcSEcCtD
Arformoterol—Urticaria—Clonidine—glaucoma	8.49e-05	0.000425	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Betaxolol—glaucoma	8.47e-05	0.000425	CcSEcCtD
Arformoterol—Body temperature increased—Clonidine—glaucoma	8.44e-05	0.000423	CcSEcCtD
Arformoterol—Abdominal pain—Clonidine—glaucoma	8.44e-05	0.000423	CcSEcCtD
Arformoterol—Rash—Pilocarpine—glaucoma	8.43e-05	0.000423	CcSEcCtD
Arformoterol—Dermatitis—Pilocarpine—glaucoma	8.43e-05	0.000422	CcSEcCtD
Arformoterol—Insomnia—Betaxolol—glaucoma	8.41e-05	0.000422	CcSEcCtD
Arformoterol—Nausea—Dorzolamide—glaucoma	8.41e-05	0.000421	CcSEcCtD
Arformoterol—Headache—Pilocarpine—glaucoma	8.38e-05	0.00042	CcSEcCtD
Arformoterol—Nausea—Travoprost—glaucoma	8.37e-05	0.00042	CcSEcCtD
Arformoterol—Dyspnoea—Betaxolol—glaucoma	8.29e-05	0.000415	CcSEcCtD
Arformoterol—Nausea—Brinzolamide—glaucoma	8.27e-05	0.000414	CcSEcCtD
Arformoterol—Palpitations—Timolol—glaucoma	8.23e-05	0.000412	CcSEcCtD
Arformoterol—Dyspepsia—Betaxolol—glaucoma	8.19e-05	0.00041	CcSEcCtD
Arformoterol—Cough—Timolol—glaucoma	8.12e-05	0.000407	CcSEcCtD
Arformoterol—Hypertension—Timolol—glaucoma	8.04e-05	0.000403	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Betaxolol—glaucoma	8.03e-05	0.000402	CcSEcCtD
Arformoterol—Fatigue—Betaxolol—glaucoma	8.02e-05	0.000402	CcSEcCtD
Arformoterol—Constipation—Betaxolol—glaucoma	7.95e-05	0.000399	CcSEcCtD
Arformoterol—Pain—Betaxolol—glaucoma	7.95e-05	0.000399	CcSEcCtD
Arformoterol—Nausea—Pilocarpine—glaucoma	7.94e-05	0.000398	CcSEcCtD
Arformoterol—Myalgia—Timolol—glaucoma	7.92e-05	0.000397	CcSEcCtD
Arformoterol—Arthralgia—Timolol—glaucoma	7.92e-05	0.000397	CcSEcCtD
Arformoterol—Chest pain—Timolol—glaucoma	7.92e-05	0.000397	CcSEcCtD
Arformoterol—Anxiety—Timolol—glaucoma	7.9e-05	0.000396	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	7.87e-05	0.000394	CcSEcCtD
Arformoterol—Hypersensitivity—Clonidine—glaucoma	7.87e-05	0.000394	CcSEcCtD
Arformoterol—Discomfort—Timolol—glaucoma	7.83e-05	0.000392	CcSEcCtD
Arformoterol—Dry mouth—Timolol—glaucoma	7.75e-05	0.000388	CcSEcCtD
Arformoterol—Asthenia—Clonidine—glaucoma	7.66e-05	0.000384	CcSEcCtD
Arformoterol—Feeling abnormal—Betaxolol—glaucoma	7.66e-05	0.000384	CcSEcCtD
Arformoterol—Oedema—Timolol—glaucoma	7.6e-05	0.000381	CcSEcCtD
Arformoterol—Anaphylactic shock—Timolol—glaucoma	7.6e-05	0.000381	CcSEcCtD
Arformoterol—Pruritus—Clonidine—glaucoma	7.56e-05	0.000379	CcSEcCtD
Arformoterol—Infection—Timolol—glaucoma	7.55e-05	0.000378	CcSEcCtD
Arformoterol—Nervous system disorder—Timolol—glaucoma	7.45e-05	0.000373	CcSEcCtD
Arformoterol—Urticaria—Betaxolol—glaucoma	7.39e-05	0.00037	CcSEcCtD
Arformoterol—Skin disorder—Timolol—glaucoma	7.38e-05	0.00037	CcSEcCtD
Arformoterol—Body temperature increased—Betaxolol—glaucoma	7.35e-05	0.000368	CcSEcCtD
Arformoterol—Diarrhoea—Clonidine—glaucoma	7.31e-05	0.000366	CcSEcCtD
Arformoterol—Hypotension—Timolol—glaucoma	7.1e-05	0.000356	CcSEcCtD
Arformoterol—Dizziness—Clonidine—glaucoma	7.06e-05	0.000354	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Timolol—glaucoma	6.92e-05	0.000347	CcSEcCtD
Arformoterol—Insomnia—Timolol—glaucoma	6.87e-05	0.000344	CcSEcCtD
Arformoterol—Hypersensitivity—Betaxolol—glaucoma	6.85e-05	0.000343	CcSEcCtD
Arformoterol—Vomiting—Clonidine—glaucoma	6.79e-05	0.00034	CcSEcCtD
Arformoterol—Dyspnoea—Timolol—glaucoma	6.77e-05	0.000339	CcSEcCtD
Arformoterol—Somnolence—Timolol—glaucoma	6.75e-05	0.000338	CcSEcCtD
Arformoterol—Rash—Clonidine—glaucoma	6.73e-05	0.000338	CcSEcCtD
Arformoterol—Dermatitis—Clonidine—glaucoma	6.73e-05	0.000337	CcSEcCtD
Arformoterol—Headache—Clonidine—glaucoma	6.69e-05	0.000335	CcSEcCtD
Arformoterol—Dyspepsia—Timolol—glaucoma	6.69e-05	0.000335	CcSEcCtD
Arformoterol—Asthenia—Betaxolol—glaucoma	6.67e-05	0.000334	CcSEcCtD
Arformoterol—Pruritus—Betaxolol—glaucoma	6.58e-05	0.00033	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Timolol—glaucoma	6.56e-05	0.000329	CcSEcCtD
Arformoterol—Fatigue—Timolol—glaucoma	6.55e-05	0.000328	CcSEcCtD
Arformoterol—Pain—Timolol—glaucoma	6.5e-05	0.000326	CcSEcCtD
Arformoterol—Diarrhoea—Betaxolol—glaucoma	6.36e-05	0.000319	CcSEcCtD
Arformoterol—Nausea—Clonidine—glaucoma	6.34e-05	0.000318	CcSEcCtD
Arformoterol—Feeling abnormal—Timolol—glaucoma	6.26e-05	0.000314	CcSEcCtD
Arformoterol—Gastrointestinal pain—Timolol—glaucoma	6.21e-05	0.000311	CcSEcCtD
Arformoterol—Dizziness—Betaxolol—glaucoma	6.15e-05	0.000308	CcSEcCtD
Arformoterol—Urticaria—Timolol—glaucoma	6.03e-05	0.000302	CcSEcCtD
Arformoterol—Body temperature increased—Timolol—glaucoma	6.01e-05	0.000301	CcSEcCtD
Arformoterol—Abdominal pain—Timolol—glaucoma	6.01e-05	0.000301	CcSEcCtD
Arformoterol—Vomiting—Betaxolol—glaucoma	5.91e-05	0.000296	CcSEcCtD
Arformoterol—Rash—Betaxolol—glaucoma	5.86e-05	0.000294	CcSEcCtD
Arformoterol—Dermatitis—Betaxolol—glaucoma	5.86e-05	0.000294	CcSEcCtD
Arformoterol—Headache—Betaxolol—glaucoma	5.83e-05	0.000292	CcSEcCtD
Arformoterol—Hypersensitivity—Timolol—glaucoma	5.6e-05	0.00028	CcSEcCtD
Arformoterol—Nausea—Betaxolol—glaucoma	5.52e-05	0.000277	CcSEcCtD
Arformoterol—Asthenia—Timolol—glaucoma	5.45e-05	0.000273	CcSEcCtD
Arformoterol—Pruritus—Timolol—glaucoma	5.37e-05	0.000269	CcSEcCtD
Arformoterol—Diarrhoea—Timolol—glaucoma	5.2e-05	0.00026	CcSEcCtD
Arformoterol—Dizziness—Timolol—glaucoma	5.02e-05	0.000252	CcSEcCtD
Arformoterol—ADRB1—Endothelin Pathways—MYLK—glaucoma	4.9e-05	0.0418	CbGpPWpGaD
Arformoterol—Vomiting—Timolol—glaucoma	4.83e-05	0.000242	CcSEcCtD
Arformoterol—Rash—Timolol—glaucoma	4.79e-05	0.00024	CcSEcCtD
Arformoterol—Dermatitis—Timolol—glaucoma	4.79e-05	0.00024	CcSEcCtD
Arformoterol—Headache—Timolol—glaucoma	4.76e-05	0.000239	CcSEcCtD
Arformoterol—Nausea—Timolol—glaucoma	4.51e-05	0.000226	CcSEcCtD
Arformoterol—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	4.04e-05	0.0344	CbGpPWpGaD
Arformoterol—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	3.68e-05	0.0314	CbGpPWpGaD
Arformoterol—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—glaucoma	3.67e-05	0.0313	CbGpPWpGaD
Arformoterol—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—glaucoma	3.35e-05	0.0286	CbGpPWpGaD
Arformoterol—CYP2A6—Tamoxifen metabolism—CYP1B1—glaucoma	3.06e-05	0.0261	CbGpPWpGaD
Arformoterol—ADRB1—Melatonin metabolism and effects—CYP1B1—glaucoma	2.71e-05	0.0231	CbGpPWpGaD
Arformoterol—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—glaucoma	2.59e-05	0.022	CbGpPWpGaD
Arformoterol—ADRB2—GPCRs, Other—PTGFR—glaucoma	2.58e-05	0.022	CbGpPWpGaD
Arformoterol—ADRB1—Melatonin metabolism and effects—EDN1—glaucoma	2.19e-05	0.0187	CbGpPWpGaD
Arformoterol—ADRB1—Endothelin Pathways—EDN1—glaucoma	1.97e-05	0.0168	CbGpPWpGaD
Arformoterol—CYP2C19—Tamoxifen metabolism—CYP1B1—glaucoma	1.87e-05	0.0159	CbGpPWpGaD
Arformoterol—ADRB1—Melatonin metabolism and effects—APOE—glaucoma	1.78e-05	0.0152	CbGpPWpGaD
Arformoterol—CYP2D6—Tamoxifen metabolism—CYP1B1—glaucoma	1.72e-05	0.0146	CbGpPWpGaD
Arformoterol—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—glaucoma	1.71e-05	0.0146	CbGpPWpGaD
Arformoterol—CYP2C9—Tamoxifen metabolism—CYP1B1—glaucoma	1.7e-05	0.0145	CbGpPWpGaD
Arformoterol—CYP2A6—Fluoropyrimidine Activity—MTHFR—glaucoma	1.51e-05	0.0128	CbGpPWpGaD
Arformoterol—CYP2C19—Melatonin metabolism and effects—CYP1B1—glaucoma	1.44e-05	0.0123	CbGpPWpGaD
Arformoterol—ADRB1—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	1.39e-05	0.0119	CbGpPWpGaD
Arformoterol—ADRB2—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	1.36e-05	0.0116	CbGpPWpGaD
Arformoterol—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—glaucoma	1.35e-05	0.0115	CbGpPWpGaD
Arformoterol—CYP2D6—Melatonin metabolism and effects—CYP1B1—glaucoma	1.33e-05	0.0113	CbGpPWpGaD
Arformoterol—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	1.32e-05	0.0113	CbGpPWpGaD
Arformoterol—CYP2A6—Oxidation by Cytochrome P450—CYP1B1—glaucoma	1.3e-05	0.0111	CbGpPWpGaD
Arformoterol—ADRB2—GPCRs, Other—SMO—glaucoma	1.3e-05	0.0111	CbGpPWpGaD
Arformoterol—CYP2A6—NRF2 pathway—SLC6A13—glaucoma	1.28e-05	0.0109	CbGpPWpGaD
Arformoterol—ADRB1—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	1.27e-05	0.0108	CbGpPWpGaD
Arformoterol—ADRB2—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	1.24e-05	0.0106	CbGpPWpGaD
Arformoterol—ADRB1—Endothelin Pathways—NOS3—glaucoma	1.2e-05	0.0103	CbGpPWpGaD
Arformoterol—CYP2C19—Melatonin metabolism and effects—EDN1—glaucoma	1.17e-05	0.00994	CbGpPWpGaD
Arformoterol—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	1.16e-05	0.00987	CbGpPWpGaD
Arformoterol—ADRB1—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	1.15e-05	0.00977	CbGpPWpGaD
Arformoterol—ADRB2—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	1.12e-05	0.00955	CbGpPWpGaD
Arformoterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	1.09e-05	0.00929	CbGpPWpGaD
Arformoterol—CYP2D6—Melatonin metabolism and effects—EDN1—glaucoma	1.07e-05	0.00914	CbGpPWpGaD
Arformoterol—CYP2A6—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	1.07e-05	0.00913	CbGpPWpGaD
Arformoterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	1.07e-05	0.00909	CbGpPWpGaD
Arformoterol—CYP2A6—NRF2 pathway—TXN—glaucoma	1.05e-05	0.00895	CbGpPWpGaD
Arformoterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	9.81e-06	0.00837	CbGpPWpGaD
Arformoterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	9.6e-06	0.00819	CbGpPWpGaD
Arformoterol—CYP2C19—Melatonin metabolism and effects—APOE—glaucoma	9.48e-06	0.00808	CbGpPWpGaD
Arformoterol—CYP2A6—NRF2 pathway—SLC6A1—glaucoma	9.36e-06	0.00798	CbGpPWpGaD
Arformoterol—CYP2C19—Arachidonic acid metabolism—CYP1B1—glaucoma	9.32e-06	0.00795	CbGpPWpGaD
Arformoterol—CYP2D6—Melatonin metabolism and effects—APOE—glaucoma	8.72e-06	0.00743	CbGpPWpGaD
Arformoterol—CYP2C9—Arachidonic acid metabolism—CYP1B1—glaucoma	8.5e-06	0.00725	CbGpPWpGaD
Arformoterol—ADRB1—GPCR ligand binding—OPN4—glaucoma	8.3e-06	0.00708	CbGpPWpGaD
Arformoterol—ADRB2—GPCR ligand binding—OPN4—glaucoma	8.12e-06	0.00692	CbGpPWpGaD
Arformoterol—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	8.05e-06	0.00687	CbGpPWpGaD
Arformoterol—CYP2C19—Oxidation by Cytochrome P450—CYP1B1—glaucoma	7.95e-06	0.00678	CbGpPWpGaD
Arformoterol—CYP2A6—NRF2 pathway—TGFB2—glaucoma	7.63e-06	0.0065	CbGpPWpGaD
Arformoterol—ADRB1—GPCR ligand binding—PTGFR—glaucoma	7.47e-06	0.00637	CbGpPWpGaD
Arformoterol—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	7.41e-06	0.00632	CbGpPWpGaD
Arformoterol—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	7.34e-06	0.00626	CbGpPWpGaD
Arformoterol—CYP2D6—Oxidation by Cytochrome P450—CYP1B1—glaucoma	7.31e-06	0.00623	CbGpPWpGaD
Arformoterol—ADRB2—GPCR ligand binding—PTGFR—glaucoma	7.31e-06	0.00623	CbGpPWpGaD
Arformoterol—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—glaucoma	7.25e-06	0.00618	CbGpPWpGaD
Arformoterol—CYP2A6—Biological oxidations—GSTT1—glaucoma	7.14e-06	0.00609	CbGpPWpGaD
Arformoterol—CYP2C19—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	6.53e-06	0.00557	CbGpPWpGaD
Arformoterol—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	6.01e-06	0.00512	CbGpPWpGaD
Arformoterol—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	5.95e-06	0.00508	CbGpPWpGaD
Arformoterol—CYP2A6—Fluoropyrimidine Activity—TP53—glaucoma	5.72e-06	0.00488	CbGpPWpGaD
Arformoterol—CYP2A6—Biological oxidations—CYP1B1—glaucoma	5.69e-06	0.00485	CbGpPWpGaD
Arformoterol—CYP2A6—NRF2 pathway—GSTM1—glaucoma	5.19e-06	0.00442	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—CA5A—glaucoma	5e-06	0.00427	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—NARFL—glaucoma	5e-06	0.00427	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—OPN4—glaucoma	4.69e-06	0.004	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—OPN4—glaucoma	4.59e-06	0.00391	CbGpPWpGaD
Arformoterol—CYP2A6—Biological oxidations—GSTM1—glaucoma	4.55e-06	0.00388	CbGpPWpGaD
Arformoterol—CYP2C19—Biological oxidations—GSTT1—glaucoma	4.35e-06	0.00371	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—OPN4—glaucoma	4.26e-06	0.00363	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—PTGFR—glaucoma	4.22e-06	0.0036	CbGpPWpGaD
Arformoterol—CYP2C19—Arachidonic acid metabolism—PTGS2—glaucoma	4.2e-06	0.00358	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—OPN4—glaucoma	4.17e-06	0.00355	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—PTGFR—glaucoma	4.13e-06	0.00352	CbGpPWpGaD
Arformoterol—CYP2D6—Biological oxidations—GSTT1—glaucoma	4e-06	0.00341	CbGpPWpGaD
Arformoterol—CYP2C9—Biological oxidations—GSTT1—glaucoma	3.97e-06	0.00338	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—PTGFR—glaucoma	3.83e-06	0.00327	CbGpPWpGaD
Arformoterol—CYP2C9—Arachidonic acid metabolism—PTGS2—glaucoma	3.83e-06	0.00327	CbGpPWpGaD
Arformoterol—ADRB1—GPCR ligand binding—SMO—glaucoma	3.77e-06	0.00321	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—PTGFR—glaucoma	3.75e-06	0.0032	CbGpPWpGaD
Arformoterol—ADRB2—GPCR ligand binding—SMO—glaucoma	3.69e-06	0.00314	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—LRP12—glaucoma	3.63e-06	0.0031	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—LRP12—glaucoma	3.55e-06	0.00303	CbGpPWpGaD
Arformoterol—CYP2C19—Biological oxidations—CYP1B1—glaucoma	3.47e-06	0.00296	CbGpPWpGaD
Arformoterol—CYP2C19—Metapathway biotransformation—CYP1B1—glaucoma	3.42e-06	0.00292	CbGpPWpGaD
Arformoterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	3.26e-06	0.00278	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—CTSA—glaucoma	3.24e-06	0.00276	CbGpPWpGaD
Arformoterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	3.19e-06	0.00272	CbGpPWpGaD
Arformoterol—CYP2D6—Biological oxidations—CYP1B1—glaucoma	3.19e-06	0.00272	CbGpPWpGaD
Arformoterol—CYP2C9—Biological oxidations—CYP1B1—glaucoma	3.16e-06	0.0027	CbGpPWpGaD
Arformoterol—CYP2D6—Metapathway biotransformation—CYP1B1—glaucoma	3.15e-06	0.00268	CbGpPWpGaD
Arformoterol—CYP2C9—Metapathway biotransformation—CYP1B1—glaucoma	3.12e-06	0.00266	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—CA5A—glaucoma	3.05e-06	0.0026	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—NARFL—glaucoma	3.05e-06	0.0026	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	2.95e-06	0.00252	CbGpPWpGaD
Arformoterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	2.85e-06	0.00243	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—NARFL—glaucoma	2.81e-06	0.00239	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—CA5A—glaucoma	2.81e-06	0.00239	CbGpPWpGaD
Arformoterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	2.79e-06	0.00238	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—CA5A—glaucoma	2.78e-06	0.00237	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—NARFL—glaucoma	2.78e-06	0.00237	CbGpPWpGaD
Arformoterol—CYP2C19—Biological oxidations—GSTM1—glaucoma	2.77e-06	0.00236	CbGpPWpGaD
Arformoterol—CYP2C19—Metapathway biotransformation—GSTM1—glaucoma	2.73e-06	0.00233	CbGpPWpGaD
Arformoterol—CYP2D6—Biological oxidations—GSTM1—glaucoma	2.55e-06	0.00217	CbGpPWpGaD
Arformoterol—CYP2C9—Biological oxidations—GSTM1—glaucoma	2.53e-06	0.00216	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—OPN4—glaucoma	2.52e-06	0.00215	CbGpPWpGaD
Arformoterol—CYP2D6—Metapathway biotransformation—GSTM1—glaucoma	2.52e-06	0.00214	CbGpPWpGaD
Arformoterol—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	2.49e-06	0.00213	CbGpPWpGaD
Arformoterol—ADRB1—GPCR ligand binding—EDN1—glaucoma	2.48e-06	0.00212	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—OPN4—glaucoma	2.46e-06	0.0021	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—CA1—glaucoma	2.44e-06	0.00208	CbGpPWpGaD
Arformoterol—ADRB2—GPCR ligand binding—EDN1—glaucoma	2.43e-06	0.00207	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—CTSA—glaucoma	2.37e-06	0.00202	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—HEYL—glaucoma	2.34e-06	0.00199	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—HEYL—glaucoma	2.29e-06	0.00195	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—PTGFR—glaucoma	2.27e-06	0.00193	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—CA2—glaucoma	2.24e-06	0.00191	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—PTGFR—glaucoma	2.22e-06	0.00189	CbGpPWpGaD
Arformoterol—ADRB1—GPCR ligand binding—C3—glaucoma	2.17e-06	0.00185	CbGpPWpGaD
Arformoterol—ADRB2—GPCR ligand binding—C3—glaucoma	2.12e-06	0.00181	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—SMO—glaucoma	1.93e-06	0.00165	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—SMO—glaucoma	1.89e-06	0.00161	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—RPTOR—glaucoma	1.77e-06	0.00151	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—RPTOR—glaucoma	1.73e-06	0.00148	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—NCK2—glaucoma	1.72e-06	0.00146	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—NCK2—glaucoma	1.68e-06	0.00143	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—TXN—glaucoma	1.57e-06	0.00134	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—CA1—glaucoma	1.49e-06	0.00127	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—HDAC9—glaucoma	1.46e-06	0.00124	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—CTSA—glaucoma	1.44e-06	0.00123	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—HDAC9—glaucoma	1.43e-06	0.00122	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—EDN1—glaucoma	1.4e-06	0.0012	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—EDN1—glaucoma	1.37e-06	0.00117	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—CA1—glaucoma	1.37e-06	0.00117	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—CA2—glaucoma	1.36e-06	0.00116	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—CA1—glaucoma	1.36e-06	0.00116	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.33e-06	0.00114	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.33e-06	0.00114	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—CTSA—glaucoma	1.33e-06	0.00113	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—CTSA—glaucoma	1.32e-06	0.00112	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—EDN1—glaucoma	1.27e-06	0.00109	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—CA2—glaucoma	1.25e-06	0.00107	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—EDN1—glaucoma	1.25e-06	0.00106	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—CA2—glaucoma	1.24e-06	0.00106	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—C3—glaucoma	1.23e-06	0.00105	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—GSTT1—glaucoma	1.22e-06	0.00104	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.21e-06	0.00104	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.21e-06	0.00104	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—C3—glaucoma	1.2e-06	0.00102	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—SMO—glaucoma	1.14e-06	0.000974	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—SMO—glaucoma	1.12e-06	0.000953	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—C3—glaucoma	1.11e-06	0.00095	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—C3—glaucoma	1.09e-06	0.000929	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—NTRK2—glaucoma	1.04e-06	0.000891	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—NTRK2—glaucoma	1.02e-06	0.000872	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—CYP1B1—glaucoma	9.73e-07	0.00083	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—ABCA1—glaucoma	9.73e-07	0.00083	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—TXN—glaucoma	9.6e-07	0.000819	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—NGFR—glaucoma	8.96e-07	0.000764	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—TXN—glaucoma	8.83e-07	0.000753	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—NGFR—glaucoma	8.77e-07	0.000748	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—APOE—glaucoma	8.76e-07	0.000747	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—TXN—glaucoma	8.75e-07	0.000747	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—glaucoma	8.68e-07	0.00074	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—NTRK1—glaucoma	8.52e-07	0.000726	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—NTRK1—glaucoma	8.33e-07	0.00071	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	7.99e-07	0.000681	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	7.91e-07	0.000675	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—CDKN2B—glaucoma	7.85e-07	0.000669	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—GSTM1—glaucoma	7.78e-07	0.000663	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—CDKN2B—glaucoma	7.68e-07	0.000655	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—EDN1—glaucoma	7.53e-07	0.000642	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—GSTT1—glaucoma	7.44e-07	0.000635	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—EDN1—glaucoma	7.37e-07	0.000628	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—NGF—glaucoma	6.92e-07	0.00059	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—MTHFR—glaucoma	6.87e-07	0.000586	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—GSTT1—glaucoma	6.85e-07	0.000584	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—GSTT1—glaucoma	6.79e-07	0.000579	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—NGF—glaucoma	6.77e-07	0.000577	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—C3—glaucoma	6.58e-07	0.000561	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—C3—glaucoma	6.44e-07	0.000549	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—APOE—glaucoma	6.4e-07	0.000546	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—CAV1—glaucoma	6.34e-07	0.000541	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—APOE—glaucoma	6.13e-07	0.000522	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—CAV1—glaucoma	6.07e-07	0.000518	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	6e-07	0.000512	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—APOE—glaucoma	5.99e-07	0.000511	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—CAV1—glaucoma	5.94e-07	0.000506	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—ABCA1—glaucoma	5.93e-07	0.000506	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—CYP1B1—glaucoma	5.93e-07	0.000506	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—FN1—glaucoma	5.78e-07	0.000493	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—BAD—glaucoma	5.71e-07	0.000487	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—FN1—glaucoma	5.65e-07	0.000482	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—BAD—glaucoma	5.58e-07	0.000476	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	5.47e-07	0.000467	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—ABCA1—glaucoma	5.46e-07	0.000465	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—CYP1B1—glaucoma	5.46e-07	0.000465	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—ABCA1—glaucoma	5.41e-07	0.000461	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—CYP1B1—glaucoma	5.41e-07	0.000461	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—NOS3—glaucoma	4.79e-07	0.000409	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—GSTM1—glaucoma	4.74e-07	0.000404	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—NOS3—glaucoma	4.59e-07	0.000391	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—NOS3—glaucoma	4.49e-07	0.000383	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—PTGS2—glaucoma	4.38e-07	0.000374	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—GSTM1—glaucoma	4.36e-07	0.000372	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—GSTM1—glaucoma	4.32e-07	0.000369	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—MTHFR—glaucoma	4.19e-07	0.000357	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—CDKN1B—glaucoma	3.98e-07	0.000339	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—APOE—glaucoma	3.9e-07	0.000333	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—CDKN1B—glaucoma	3.89e-07	0.000332	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—CAV1—glaucoma	3.87e-07	0.00033	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—MTHFR—glaucoma	3.85e-07	0.000329	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—MTHFR—glaucoma	3.82e-07	0.000326	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—MMP9—glaucoma	3.68e-07	0.000314	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—MMP9—glaucoma	3.6e-07	0.000307	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—APOE—glaucoma	3.59e-07	0.000306	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—APOE—glaucoma	3.56e-07	0.000303	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—CAV1—glaucoma	3.56e-07	0.000303	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—CAV1—glaucoma	3.52e-07	0.000301	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—VEGFA—glaucoma	3.31e-07	0.000282	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—VEGFA—glaucoma	3.23e-07	0.000276	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—NOS3—glaucoma	2.92e-07	0.000249	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—NOS3—glaucoma	2.69e-07	0.000229	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—PTGS2—glaucoma	2.67e-07	0.000228	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—NOS3—glaucoma	2.67e-07	0.000227	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—TP53—glaucoma	2.5e-07	0.000213	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—PTGS2—glaucoma	2.46e-07	0.00021	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—TP53—glaucoma	2.44e-07	0.000208	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—PTGS2—glaucoma	2.44e-07	0.000208	CbGpPWpGaD
